{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:31:44Z","timestamp":1782837104223,"version":"3.54.5"},"reference-count":68,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Peripartum cardiomyopathy (PPCM) is a distinct condition that presents as heart failure (HF) in a woman who was previously healthy and has no prior cardiovascular issues. It results from idiopathic left ventricular (LV) dysfunction, characterized by a reduced LV ejection fraction below 45%. PPCM is a life-threatening condition with a high mortality rate (MR) that demands urgent treatment. Methods: This narrative review aims to define PPCM and its pathophysiology and conduct a scoping review of the latest data on the management of patients with peripartum cardiomyopathy during pregnancy and the postpartum period. Results: Currently, treatment follows standard HF protocols for reduced ejection fraction, with the possible addition of bromocriptine, and during pregnancy, medications that do not harm the fetus. Conclusions: Early, aggressive therapy is essential for a better prognosis, but managing PPCM can be challenging. Treatment of PPCM patients should be led by a team of highly qualified specialists, known as the Obstetric and Cardiac Care Team, comprising an obstetrician-perinatologist, an anesthesiologist, a cardiologist, and a cardiac intensive care specialist. Baseline left ventricular end-diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) are the main prognostic factors. LVEF less than 30%, significant LV dilatation, LVEDD \u2265 6.0 cm, and right ventricular involvement are factors indicative of a poor prognosis. While pregnancy after PPCM is possible, it should be discouraged due to the significant risk of complications and even death. The most common causes of death in patients with PPCM are thromboembolic complications, severe HF, serious ventricular arrhythmias, cardiogenic shock, and sudden cardiac arrest.<\/jats:p>","DOI":"10.3390\/jcm15082974","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:29:08Z","timestamp":1776162548000},"page":"2974","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peripartum Cardiomyopathy: Current Insights into Pathogenesis and Clinical Management: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2602-4249","authenticated-orcid":false,"given":"Marzena","family":"Laskowska","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Perinatology, Medical University of Lublin, Al. Rac\u0142awickie 1, 20-069 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/1471-0528.17645","article-title":"Cardiogenic shock in pregnancy","volume":"131","author":"Greer","year":"2024","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_2","first-page":"e20240807","article-title":"REBECGA: Brazilian Registry of Heart Disease and Pregnancy. Multicenter Epidemiological Study of Heart Diseases in Pregnancy: Retrospective Cohort","volume":"122","author":"Avila","year":"2025","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1093\/eurheartj\/ehaf193","article-title":"2025 ESC Guidelines for the management of cardiovascular disease and pregnancy","volume":"46","author":"Haugaa","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/ejhf.2871","article-title":"Investigators of the ESC EORP PPCM Registry. Thromboembolic events in peripartum cardiomyopathy: Results from the ESC EORP PPCM registry","volume":"25","author":"Tromp","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5603\/KP.2019.0049","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"77","author":"Bauersachs","year":"2019","journal-title":"Pol. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/JMDH.S372747","article-title":"Peripartum Cardiomyopathy: Risks, Diagnosis and Management","volume":"16","author":"Carlson","year":"2023","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"ytaf306","DOI":"10.1093\/ehjcr\/ytaf306","article-title":"Delayed recognition of peripartum cardiomyopathy presenting with severe heart failure: A case report","volume":"9","author":"Asri","year":"2025","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_10","first-page":"235","article-title":"Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: Results from the PEACE Registry","volume":"7","author":"Karaye","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2306667","article-title":"Peripartum Cardiomyopathy","volume":"390","author":"Arany","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kryczka, K.E., Demkow, M., and Dzieli\u0144ska, Z. (2024). Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found. Biomolecules, 14.","DOI":"10.3390\/biom14010103"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines on the management of cardiovascular diseases during pregnancy, the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"39","author":"Bauersachs","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5603\/FC.2022.0062","article-title":"The role of multidisciplinary care for pregnant women with a positive cardiological history in everyday medical practice","volume":"17","author":"Iwan","year":"2022","journal-title":"Folia Cardiol."},{"key":"ref_15","first-page":"100107","article-title":"ROPAC Investigators Group, ROPAC Executive Committee. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)","volume":"3","author":"Ramlakhan","year":"2021","journal-title":"Int. J. Cardiol. Congenit. Heart. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1093\/eurheartj\/ehx428","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: Welcome on BOARD","volume":"38","author":"Arrigo","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/eurheartj\/ehv009","article-title":"Peripartum cardiomyopathy: Current management and future perspectives","volume":"36","author":"Haghikia","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1253\/circj.CJ-16-1193","article-title":"Imbalanced angiogenesis in peripartum cardiomyopathy\u2014Diagnostic value of placenta growth factor","volume":"81","author":"Mebazaa","year":"2017","journal-title":"Circ. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"H46","DOI":"10.1152\/ajpheart.00073.2016","article-title":"Acute exposure to progesterone attenuates cardiac contraction by modifying myofilament calcium sensitivity in the female mouse heart","volume":"312","author":"Feridooni","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-med-041316-090545","article-title":"Understanding Peripartum Cardiomyopathy","volume":"69","author":"Arany","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Kaminski","year":"2007","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"eaat4822","DOI":"10.1126\/scitranslmed.aat4822","article-title":"Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome","volume":"11","author":"Habashi","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.118.10888","article-title":"Activin A and late postpartum cardiac dysfunction among women with hypertensive disorders of pregnancy","volume":"72","author":"Shahul","year":"2018","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/CIRCRESAHA.117.311456","article-title":"PDK4 Inhibits Cardiac Pyruvate Oxidation in Late Pregnancy","volume":"121","author":"Liu","year":"2017","journal-title":"Circ. Res."},{"key":"ref_25","first-page":"e33159","article-title":"Anesthetic Management in Peripartum Cardiomyopathy: A Contemporary Review","volume":"14","author":"Nayak","year":"2022","journal-title":"Cureus"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9378(93)90479-3","article-title":"Peripartum heart failure associated with prolonged tocolytic therapy","volume":"168","author":"Lampert","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCULATIONAHA.120.052395","article-title":"Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy","volume":"143","author":"Goli","year":"2021","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/eurheartj\/ehaa455","article-title":"Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: An ESC EORP registry","volume":"41","author":"Sliwa","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/S0140-6736(25)01451-5","article-title":"Peripartum cardiomyopathy","volume":"406","author":"Sliwa","year":"2025","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis, and management of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/1995-705X.185114","article-title":"One-Year Survival in Nigerians with Peripartum Cardiomyopathy","volume":"17","author":"Karaye","year":"2016","journal-title":"Heart Views"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"131596","DOI":"10.1016\/j.ijcard.2023.131596","article-title":"EURObservational Research Programme, in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registry","volume":"398","author":"Sliwa","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/eurheartj\/ehae559","article-title":"Bromocriptine treatment and outcomes in peripartum cardiomyopathy: The EORP PPCM registry","volume":"46","author":"Viljoen","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_35","unstructured":"Working Group on the Management of Cardiomyopathies (2023). ESC 2023 Guidelines for the Management of Cardiomyopathies. Developed by the European Society of Cardiology (ESC). Pol. Cardiol., 44, 3503\u20133626."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.repc.2023.01.029","article-title":"Peripartum cardiomyopathy: A review","volume":"42","author":"Bala","year":"2023","journal-title":"Rev. Port. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIR.0000000000000300","article-title":"Cardiac arrest in pregnancy: A scientific statement from the American Heart Association","volume":"132","author":"Jeejeebhoy","year":"2015","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccep.2015.03.010","article-title":"Arrhythmias in peripartum cardiomyopathy","volume":"7","author":"Honigberg","year":"2015","journal-title":"Card. Electrophysiol. Clin."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"k5287","DOI":"10.1136\/bmj.k5287","article-title":"Peripartum cardiomyopathy","volume":"364","author":"Honigberg","year":"2019","journal-title":"BMJ"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ehf2.14210","article-title":"Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy","volume":"10","author":"Pfeffer","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMcp1407434","article-title":"Clinical Practice. Pregnancy Complicated by Venous Thrombosis","volume":"373","author":"Greer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum Cardiomyopathy: JACC State-of-the-Art Review","volume":"75","author":"Davis","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","first-page":"e939919","article-title":"Eclampsia: A Critical Pregnancy Complication Demanding Enhanced Maternal Care: A Review","volume":"29","author":"Laskowska","year":"2023","journal-title":"Med. Sci. Monit."},{"key":"ref_44","first-page":"315","article-title":"Peripartum cardiomyopathy: Still unknown: The current state of knowledge","volume":"14","author":"Nguyen","year":"2019","journal-title":"Folia Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jacbts.2019.03.005","article-title":"To Breastfeed or Not to Breastfeed with Peripartum Cardiomyopathy","volume":"4","author":"Arany","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ejhf.586","article-title":"Current management of patients with severe acute peripartum cardiomyopathy: Practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"18","author":"Bauersachs","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_47","first-page":"39","article-title":"Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy","volume":"36","author":"Labbene","year":"2017","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10741-020-09991-3","article-title":"Ventricular arrhythmias and ARNI: Is it time to reappraise their management in the light of new evidence?","volume":"27","author":"Vecchi","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bodnar, P., Mazurkiewicz, M., Chwalba, T., Romuk, E., Ciszek-Chwalba, A., Jache\u0107, W., and Wojciechowska, C. (2023). The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress-Role of New Drugs, Flozins. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082236"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lin, X., Zhang, H., Zhao, S., Chen, L., Li, J., Wang, X., and Tian, W. (2022). The Efficacy and Safety of the Combined Therapy of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitor in Patients with Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Sub-Analysis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.882089"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1002\/ehf2.13644","article-title":"ARNI versus ACEI\/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction","volume":"8","author":"She","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0267659116681436","article-title":"Veno-venous ECMO as a safe bridge to recovery in a patient with severe peripartum cardiomyopathy\u2014Learning from errors","volume":"32","author":"Ull","year":"2017","journal-title":"Perfusion"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.hlc.2021.03.276","article-title":"Concomitant ECMO And IABP Support in Postcardiotomy Cardiogenic Shock Patients","volume":"30","author":"Djordjevic","year":"2021","journal-title":"Heart Lung Circ."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jawad, K., Koziarz, A., Dieterlen, M.T., Garbade, J., Etz, C.D., Saeed, D., Langer, E., Stepan, H., Scholz, U., and Krause, M. (2022). Long-term follow-up of mechanical circulatory support in peripartum cardiomyopathy (PPCM) refractory to medical management: A multicenter study. Life, 12.","DOI":"10.3390\/life12010087"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10741-021-10185-8","article-title":"Effects of bromocriptine in peripartum cardiomyopathy: A systematic review and meta-analysis","volume":"27","author":"Trongtorsak","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacbts.2019.01.010","article-title":"Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy","volume":"4","author":"Koczo","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: A multicentre randomized study","volume":"38","author":"Haghikia","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study","volume":"121","author":"Sliwa","year":"2010","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00392-018-1355-7","article-title":"Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction","volume":"108","author":"Haghikia","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00392-022-02101-3","article-title":"Effectiveness of implantable loop recorder and Holter electrocardiographic monitoring for the detection of arrhythmias in patients with peripartum cardiomyopathy","volume":"112","author":"Hoevelmann","year":"2023","journal-title":"Clin. Res. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Writing Committee Members, and ACC\/AHA Joint Committee Members (2022). 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure. J. Card. Fail., 28, e1\u2013e167.","DOI":"10.1016\/j.cardfail.2022.03.346"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical outcomes for peripartum cardiomyopathy in North America: Results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy)","volume":"66","author":"McNamara","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e008378","DOI":"10.1161\/JAHA.117.008378","article-title":"Initial Right Ventricular Dysfunction Severity Identifies Severe Peripartum Cardiomyopathy Phenotype with Worse Early and Overall Outcomes: A 24-Year Cohort Study","volume":"7","author":"Peters","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ehf2.12059","article-title":"Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: A cardiovascular magnetic resonance study","volume":"2","author":"Haghikia","year":"2015","journal-title":"ESC Heart Fail."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/HYPERTENSIONAHA.119.13291","article-title":"Importance of Early Diagnosis in Peripartum Cardiomyopathy","volume":"75","author":"Lewey","year":"2020","journal-title":"Hypertension"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Biljic-Erski, A., Rajovic, N., Pavlovic, V., Bulumiric, Z., Rakic, A., Rovcanin, M., Stulic, J., Anicic, R., Kocic, J., and Cumic, J. (2025). Hypertensive Disorders of Pregnancy and Peripartum Cardiomyopathy: A Meta-Analysis of Prevalence and Impact on Left Ventricular Function and Mortality. J. Clin. Med., 14.","DOI":"10.3390\/jcm14051721"},{"key":"ref_67","first-page":"349","article-title":"Low STAT3 expression sensitizes to toxic effects of \u03b2-adrenergic receptor stimulation in peripartum cardiomyopathy","volume":"38","author":"Stapel","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11936-021-00915-4","article-title":"Counseling women with peripartum cardiomyopathy about subsequent pregnancies","volume":"23","author":"Joseph","year":"2021","journal-title":"Curr. Treat. Options Cardiovasc. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2974\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:57:15Z","timestamp":1776164235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15082974"],"URL":"https:\/\/doi.org\/10.3390\/jcm15082974","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}